Immune mediated diseases (IMDs) arise from a lack of immune tolerance, causing chronic 5 inflammation. Despite their growing prevalence, targeted therapies to treat IMDs are lacking. 6
Introduction 26
Autoimmune and atopic diseases may arise due to a lack of immune tolerance towards self-antigen or 27 harmless allergens respectively 1 . Loss of immune tolerance results in recurrent or chronic 28 inflammation, causing damage to healthy tissues and extensive morbidity. The incidence of immune-29 mediated diseases (IMDs) has drastically increased in recent decades, highlighting the need for a 30 clearer understanding of their pathogeneses and effective drug discovery 2 . Cytokines and growth 31 factors (herein referred to as cytokines) are signalling factors which orchestrate the balance between 32 immune homeostasis and inflammation 3 . However, traditional observational epidemiological studies 33 are prone to confounding and reverse causation, making it challenging to disentangle causal effects 34 of individual cytokines on IMDs 4 . 35
Genome-wide association studies (GWAS) have been instrumental in identifying large numbers of 36 genetic loci which influence disease risk. This includes associations between loci which harbour genes 37 responsible for the synthesis of cytokines and their receptors with autoimmune diseases such as 38 inflammatory bowel disease (IBD) 5-8 , multiple sclerosis (MS) 9-11 , rheumatoid arthritis (RA) 12 and 39 systemic lupus erythematosus (SLE) 13 , as well as atopic diseases such as eczema 14 and asthma 15 . This 40 suggests that particular inflammatory cytokines may have a causal effect on the development of these 41 diseases 4 . Previous studies have not yet integrated genome-wide association and cytokine loci data 42 with cell or tissue-specific gene expression loci data to characterise the molecular basis of IMD 43 pathogenesis. Identifying immune-cell specific disease-drivers, as well as putative causal relationships 44 between cytokines and IMDs, will help to elucidate complex IMD pathways and identify drug target 45 candidates for therapeutic intervention. Furthermore, targets supported by evidence from statistical 46 analyses of human genetic data are thought to have double the success rate in clinical development 16 .
3 Mendelian randomization (MR) is an increasingly popular statistical method used to strengthen causal 48 inference with respect to exposure-disease associations within human populations, in the absence of 49 confounding variables. MR uses single nucleotide polymorphisms (SNPs), identified through GWAS, as 50 unconfounded proxies for an exposure of interest, analogous to a randomized controlled trial 17 . In this 51 study, we used a conservative (single SNP) and liberal (multiple SNPs) two-sample MR analysis to 52 investigate associations between 10 circulating inflammatory biomarkers (cytokines or cytokine 53 receptors 18-23 ) (Table S1) and 9 IMDs (Table S2) . We subsequently used the recently-developed 54 multiple-trait colocalization (moloc) method 24 , integrating either immune cell or tissue expression 55 quantitative expression loci (eQTL), cytokine protein QTL (pQTL) and IMD-associated loci data, to 56 identify immune cell and tissue-specific drivers of inflammatory disease. 57
Methods and Materials

58
Data Sources 59
For our two-sample MR analysis, we harnessed genetic instrument data for 10 circulating 60 inflammatory cytokines or soluble cytokine receptors (Table 1 ) from summary statistics of previously 61 published GWAS 18-20; 25 . The SNP used as an instrument for IL-6R affected levels of soluble IL-6R. The 62 SNPs chosen in this analysis have been shown to be robustly associated with a change in circulating 63 levels of a cytokine (P < 5 x 10 -8 ) and are in cis with the gene of interest (i.e. the SNP was located within 64 a 1MB distance of the gene which encoded the cytokine or cytokine receptor of interest). Data 65 concerning IMD outcomes (Table 2) were derived from large-scale GWAS using the MR-Base 66 platform 26 . For the moloc analysis, we harnessed human monocyte (CD14 + CD16 -), neutrophil (CD16 + 67 CD66b + ) and T cell (CD4 + CD45RA + ) eQTL data from the BLUEPRINT epigenome project 27 . All data used 68 were derived from populations of European descent. 69
Mendelian Randomization 70
Mendelian randomization follows 3 assumptions; that the selected instruments used are robustly 71 associated with the exposure (1), that the selected instruments are unconfounded (2), and that the 72 selected instruments can only influence the outcome via the exposure (3). Using randomly-inherited 73 unmodifiable SNPs associated with circulating inflammatory cytokine levels through GWAS as genetic 74 instruments for MR satisfies assumptions 1 and 2. We performed two-sample MR with the MR-Base 75 platform 26 , using two different analysis methods (Figure S1A) as described below, depending upon 76 available data: 77
Conservative two-sample MR was used to analyse the causal effect of cytokines using SNPs at target 78 genes encoding the inflammatory biomarkers of interest. As such, for this analysis we used a single 79 SNP acting in cis as a genetic instrument (i.e. located within a 1MB distance of the target gene 80 encoding the cytokine with P < 5 x 10 -08 ). As only one genetic instrument was used in this analysis, 81 effect estimates were based on the Wald ratio test: 82
where ̂ | is the coefficient of the genetic variant in the regression of the exposure (e.g. circulating 85 cytokine level) and ̂ | is the coefficient of the genetic variant in the regression of the outcome. 86
Where possible, liberal MR was also used to analyse the causal effect of circulating inflammatory 87 biomarkers on immune-mediated diseases. In contrast to the conservative MR analysis, liberal MR 88 used multiple SNPs as genetic instruments which were either acting in cis or trans (i.e. over 1MB 89 distance from the target gene encoding the cytokine with P < 5 x 10 -08 ). To identify instruments for the 90 liberal MR we undertook genome-wide LD clumping based on P < 5 x 10 -08 and r 2 < 0.001. A leave-one-91 out MR analysis was performed in parallel with liberal MR to ensure that causal effects were not 92 observed due to the influence of a single SNP. As two or more genetic instruments were available for 93 liberal MR, we used the inverse variance weighted (IVW) method to obtain MR effect estimates: 94
Where X is the exposure, Y is the outcome and the genetic variants are k (where k = 1,…,n). 97
For both conservative and liberal MR analyses, we used the Bonferroni correction to calculate an 98 adjusted P value threshold (conservative: P ≤ 6.17 x 10 -4 , liberal: P ≤ 6.94 x 10 -4 ) to account for multiple 99 testing, where: 100
X .
101
We subsequently undertook reverse MR analyses for all associations which survived multiple testing 102 to investigate reverse causation (i.e. the likelihood that genetic predisposition to disease has an 103 influence on inflammatory cytokine levels). As an additional sensitivity analysis, we used the MR 104
Steiger directionality test to assess the directionality of associations between inflammatory cytokines 105 and complex traits 28 . 106
Multiple Trait Colocalization Analysis 107
We applied the moloc approach 24 to immune cell-specific expression quantitative trait loci (eQTL) 108 data, inflammatory biomarker protein QTL (pQTL) data, and IMD-associated loci data, to identify 109 putative immune cell-specific drivers of IMDs ( Figure S1B ). The moloc method uses a Bayesian 110 statistical framework to calculate PPA (posterior probability of association) scores to measure the 111 degree of colocalization between gene loci using 3 or more datasets. PPA scores of ≥ 80% are likely to 112 share a common genetic causal variant based on evaluations undertaken by the authors 24 . We 113 obtained eQTL data derived from concerning neutrophils (CD16 + CD66b + ), monocytes (CD14 + CD16 -), 114 and T cells (CD4 + CD45RA + ) 27 . We ran independent analyses for each of the 3 immune cell-types, 115 testing the degree of colocalization between immune cell eQTL, with inflammatory biomarker pQTL 116 and IMD-associated loci. 117
We chose to perform moloc for inflammatory biomarkers and IMDs in this instance based upon a P-118 value threshold < 0.05 in either the conservative or liberal MR analysis. Along with investigating cell-119 type specificity for identified associations, this analysis was used to detect evidence of a coordinated 120 system which is consistent with causality (i.e. gene expression and respective protein products 121 colocalize with the associated complex traits). As such these findings can complement evidence from 122 MR to detect putative causal effects between biomarkers and disease. 123
Finally, we undertook moloc analyses to investigate gene expression within different tissue types using 124 data from the GTEx consortium v6p 29 . Our 3 traits in each analysis were the circulating inflammatory 125 cytokine using pQTL data, the complex trait with strongest evidence of association with the cytokine 126 in either the liberal or conservative MR analyses, and tissue-specific gene expression for the cytokine 127 using GTEx eQTL data. We only investigated tissue-types with at least one eQTL (P < 1.0 x 10 -04 ) for the 128 target cytokine gene. As in the immune-cell eQTL moloc analysis, evidence of colocalization was based 129 on a PPA score of ≥ 80%. 130
All statistical and bioinformatics analyses were undertaken using R statistical software version 3.31 30 . 131
Plots illustrating multiple trait colocalization were generated using base R graphics, whereas our 132 volcano plot was generated using ggplot 31 . 133
Results
134
Mendelian Randomization Analyses Identify Putative Causal Relationships Between Circulating 135
Cytokine/Cytokine Receptor Levels and IMDs 136
We first used a conservative MR approach to detect associations between inflammatory biomarkers 137 and IMDs, using a single cis-acting SNP instrument for the inflammatory biomarker gene of interest. 138 IP-10 and TRAIL were removed from the analysis as the SNP identified as instruments 18 had minor 139 allele frequencies too rare (< 0.05) to undertake formal two-sample MR. Results from the conservative 140 MR analysis are displayed in Figure 1 and Table S3 . Based on a Bonferroni corrected P-value threshold 141 of P ≤ 6.17 x 10 -4 , we identified associations between soluble IL-6R levels and eczema/dermatits (P = 142 1.35 x 10 -8 ), rheumatoid arthritis (RA) (P = 5.67 x 10 -8 ), Crohn's disease (CD) (P = 2.81 x 10 -5 ) and Asthma 143 (P = 1.12 x 10 -4 ), as well as an association between IL-2Rα levels and multiple sclerosis (MS) (P = 1.75 144
x 10 -5 ). 145
We next performed a liberal MR analysis using all available instruments (i.e. acting in either cis or 146 trans), associated with our inflammatory biomarkers (Exposure, Table S1) as instruments. IL-6R (SNPs 147 affecting levels of soluble IL-6R only), MIF, and IL-2Rα were excluded from the liberal analysis as there 148 was only one remaining SNP available for MR after LD clumping to remove SNPs in linkage 149 disequilibrium with one another. We adjusted our Bonferroni corrected P value threshold to account 150 for the change in the number of tests and applied the new threshold of P ≤ 6.14 x 10 -4 to the liberal 151 MR results. From this analysis we found evidence to suggest there may be causal relationships 152 between circulating levels of IL-18 and inflammatory bowel disease (IBD) (P = 1.17 x 10 -4 ) and 153 eczema/dermatitis (P = 2.81 x 10 -3 ). These associations were not detected in the conservative analysis 154 using the IL-18 SNP (rs71478720) alone (P = 1.06 x 10 -2 , E/D: P = 2.81 x 10 -3 ), although using multiple 155 instruments in the liberal MR provided much stronger evidence of association. 156
One of the advantages of the liberal MR analysis is that sensitivity analyses can be performed to test 157 the robustness and the direction of putative inferred causal relationships. Thus, we next conducted a 158 leave one out analysis to ensure that no single SNP from the instruments was responsible for the 159 observed effect. Both the analyses of IL-18 on IBD ( Figure 2 ) and on eczema/dermatitis ( Figure S2 ) 160 survived leave-one-out analyses (Table S5) , as the removal of any individual SNP from the analysis had 161 little effect on observed effect estimates. These results provide evidence to support a causal role for 162 circulating IL-18 levels in the pathogenesis of IBD and eczema/dermatitis. Moreover, reverse MR 163 (Table S6 ) and the Steiger directionality test 28 (Table S7 ) showed that reverse causation was unlikely 164 for any of the associations identified in either the conservative or liberal MR analysis. 165 166
Multiple-trait Colocalization Uncovers Immune Cell-Specific Drivers of IMD 167
We next investigated the cell-type specificity for the detected putative drivers of IMD using eQTL data 168 from the BLUEPRINT consortium 27 . For circulating inflammatory biomarkers and IMDs where evidence 169 of a causal association was detected using MR, we applied the moloc method using eQTL data for the 170 gene encoding the target inflammatory biomarker, pQTL data for the circulating inflammatory 171 biomarker itself and GWAS summary statistics for the associated complex trait ( Figure S1B ). We tested 172 whether immune-cell eQTL (a) colocalised with pQTL (b) and IMD-associated loci (c) The moloc analysis 173 was performed 3 times for each association, using eQTL from either human CD14 + CD16monocytes 174 (a1), CD16 + CD66b + neutrophils (a2) or CD4 + CD45RA + T cells (a3). 175
We found evidence of multiple-trait colocalization between 10 combinations of immune-cell eQTL, 176 IMD-associated loci, and inflammatory biomarker pQTL (Table S8 ). PPA scores measuring 177 colocalization of genetic signals between all 3 traits (PPAabc) indicated that monocytes (PPAa1bc = 178 0.8812) and neutrophils (PPAa2bc = 0.9657), but not T cells (PPAa3bc = 0.0159), may drive IBD via IL-18 179 ( Figure 3A) . Additionally, we found evidence of a T cell-specific role in the disease pathways of 180 eczema/dermatitis (PPAa3bc = 0.9115) driven by soluble IL-6R ( Figure 3B ). IL-2Rα pQTL, MS-associated 181 loci and T cell eQTL showed evidence of colocalization (PPAa3bc = 0.8826), but there were no IL-2Rα 182 eQTL data within monocytes or neutrophils in the BLUEPRINT study. 183
In the tissue-specific analysis, the association between IL18 and IBD was relatively ubiquitous, as 184 evidence of colocalization was observed within 7 diverse tissue types (Table S9) the likelihood of causal relationships between exposures and traits in human populations 37 . In this 201 study, we developed a framework that integrates MR with multiple-trait colocalization to gain insights 202 into the molecular basis of IMD pathogenesis. Using this framework, we found evidence to support 203 causal relationships between levels of: circulating IL-18 and IBD, as well as eczema/dermatitis, 204 circulating soluble IL-6R and eczema/dermatitis, and circulating IL-2Rα and MS, amongst others 205 (Tables S3-4 , S6-8). Additionally, we provided evidence to suggest that these associations are likely to 206 be driven in an immune-cell and tissue-specific manner. We believe our analysis framework could be 207 applied by other studies with alternative hypotheses, as a way of disentangling complex biochemical 208 cell signalling pathways and identifying molecules and cell-types which are likely to drive disease. 209 A T cell-mediated role for IL-2/IL-2Ra in MS has already been well established through epidemiological 210 and lab-based studies 10; 38 . The IL-2R-targetting drug daclizumab was given FDA approval for the 211 treatment of MS, but was recently withdrawn due to serious side-effects 39-41 . Additionally, a causal 212 role for IL-18R in atopic dermatitis has recently been described, by integrating MR and pQTL-data 42 . 213
Our results provide additional evidence to support these existing findings, as well as identifying 214 monocytes and neutrophils as potential drivers of the relationship between IL-18 and 215 eczema/dermatitis (Table S8 ). However, the associations between soluble IL-6R variation and 216 eczema/dermatitis, or IL-18 and IBD within human populations are less well understood. Our analyses 217 not only help establish evidence for causal relationships between these inflammatory biomarkers and 218
IMDs, but also help characterize their cell-type specific nature. 219 IL-18, a member of the IL-1 superfamily of cytokines, is a potent inducer of Th1 mediated inflammation 220 and INF-γ production 43 . This cytokine was first linked to IBD nearly 20 years ago, where it was shown 221 to be highly expressed in intestinal tissues derived from IBD patients, compared to healthy control 222 patients 44 . Using murine IBD models, deletion of il-18 or its receptor il-18r1 has been shown to be 223 protective against inducible-colitis, by controlling goblet cell function and maintaining intestinal 224 barrier homeostasis 45 . Despite strong evidence to suggest a role for IL-18 in IBD in mice, whether there 225 was a causative role within human populations remained unclear. Our study provides evidence that 226 IL-18 is likely the causal gene responsible for the association with IBD at this locus, as well as out MR 227 analysis supporting a causal role for IL-18 in the disease pathogenesis of IBD within human 228 populations. Furthermore, the moloc analyses suggested that innate immune cells such as monocytes 229 and neutrophils are likely to drive this association, supporting the current dogma that innate 230 production of IL-18 stimulates Th1/Th17-mediated autoimmunity in IBD 47 . The T cell-specific eQTL 231 data currently available for moloc analyses concerned naïve CD4 + T cells 27 . More eQTL data concerning 232 activated and differentiated immune cell subsets, such as macrophages, dendritic cells and T helper 233 cell subsets (i.e. Th1, Th2, Th17, Treg) are required for additional immune cell subset-specific moloc 234 analysis, to further elucidate the molecular pathways which drive IMDs. However, this data may be 235 difficult to acquire on a large-scale. Although eQTL data for many tissue types are now readily 236 available 29 , moloc analysis using tissue-specific eQTL data concerning tissues which are known to 237 become inflamed during IMDs would help to indicate whether cytokine or cytokine receptor 238 expression in certain tissue types drives IMDs. For example, eQTL data from the different layers within 239 the intestine would help to further unravel which roles inflammatory biomarkers are likely play in 240 driving inflammation during IBD, in a tissue-context-dependent manner. 241 IL-6R is the receptor of the pro-inflammatory cytokine IL-6, which can exist in a membrane-bound 242 state (classical) to the surface of leukocytes and hepatocytes, or in soluble form (trans) 48 . Both, 243 classical and trans IL-6R signalling culminates in the expression of signal transducer and activator of 244 transcription (STAT)3, which promotes inflammation via the expression of genes encoding 245 antiapoptotic proteins and cytokines 49 . However, classical IL-6 signalling can act on few cell types 246 compared to trans IL-6 signalling, which can act on any cell which has the cell-bound signal transducer, 247 gp130 50 . One GWAS previously reported the an association between elevated soluble IL-6R levels 248 resulting from a SNP in IL-6R and atopic dermatitis 51 . We provide evidence from the conservative MR 249 and moloc analyses that supports a causal role between soluble IL-6R and eczema/dermatitis. Levels 250 of membrane-bound IL-6R (leading to classical IL-6 signalling) and soluble IL-6R (trans IL-6 signalling) 251 fluctuate as a result of receptor shedding by cells expressing membrane-bound IL-6R, as wells changes 252 to the amount of receptor being synthesised by cells 50 . Moreover, the ratio of classical to trans IL-6 253 signalling also depends upon levels of IL-6 and cell-bound gp130. Therefore, analyses combining 254 instruments which affect the classical or trans signalling pathways would provide a clearer insight into 255 the role of IL-6 signalling in disease. Interestingly, activated CD4 + T cells have been shown increase 256 levels of soluble IL-6R, by shedding their membrane-bound IL-6R; this mechanism is thought to have 257 a role in the development of autoimmune diseases, which are often mediated by autoreactive T cells 258 52; 53 . Through the moloc analysis, we showed that eczema/dermatitis was likely to be driven by IL-6R 259 expression in T cells ( Figure 3B , Table S8 ), a finding which is supported by evidence of increased IL-6R 260 shedding leading to an increase in soluble IL-6R in people diagnosed with atopic dermatitis compared 261 to healthy controls 51 . 262
Relatively few SNPs have been associated with changes in the circulating inflammatory biomarkers 263 investigated in this study, as most of the GWAS summary statistics used to identify our instruments 264 were derived from cohorts with fewer than 9000 people 18-20 ; this is likely due to the high cost of 265 quantification of circulating cytokines and cytokine receptors from blood. Our reverse MR analysis 266 may therefore have been underpowered to evaluate evidence of reverse causation, although 267 supplementing this analysis using the Steiger directionality test also suggested that this was unlikely 268 for the associations we identified. As sample sizes for GWAS of circulating cytokines increase, the 269 analysis pipeline illustrated by this study will have further power to detect novel relationships between 270 markers of inflammation and complex disease. 271
In conclusion, in this study we have found strong evidence supporting new and known causal, 
